Ischaemic colitis in a patient taking meloxicam

Lancet

Volumn 357, Issue 9257, 2001, Pages 690-

  Garcia, Bruno ^a   Ramaholimihaso, Fidy ^a   Diebold, Marie Danièle ^a   Cadiot, Guillaume ^a   Thiéfin, Gérard ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MELOXICAM;

ADULT; ARTICLE; BLOOD SAMPLING; CASE REPORT; COLITIS; COLONOSCOPY; DIARRHEA; DRUG INDUCED DISEASE; DRUG SAFETY; ENZYME INHIBITION; FEMALE; HISTOPATHOLOGY; HUMAN; INTESTINE ISCHEMIA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0035799138     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04141-6     Document Type: Article

References (5)

1. Non-steroidal anti-inflammatory drugs and segmental non-gangrenous colitis: A case-control study
2. COX-2 inhibitors
3. A 4-week, double-blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptom evaluation in healthy volunteers
4. COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: A double blind crossover study comparing rofecoxib with placebo and indomethacin
5. Cyclooxygenase-2-derived prostaglandin D2 is an early anti-inflammatory signal in experimental colitis